26.08.2016 • NewsDede WillamsRecipharmmanufacturer

Recipharm Lifts Italian Lyophilization Capacity

Sweden-based drug developer and toll manufacturer Recipharm is investing €3.7 million in expanding its lyophilization capacity at Masate, Italy, near Milan. The company said the expansion, which is in response to growing customer demand, forms part of its strategy to become a leading lyophilization provider and at the same time complements its €32 million investment in a capacity increase at Wasserburg, Germany.

Recipharm’s Masate, facility specializes in aseptic manufacturing and filling of parenteral and offers lyophilization capabilities in both vials and ampoules. Part of the expansion will be the introduction of a new lyophilizer for vials, increasing output capability by about 20%.

The new lyophilization machinery will allow the toll manufacturer to support more drug developers with their stability challenges and help meet growing demand for lyophilization services from both small and large drugmakers, particularly in Europe, China and Japan, general manager Giorgio Bruno said.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.